Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06908629

Addressing Social Determinants of Health (SDOH) Among Metro Detroit Cancer Survivors: A Pilot Feasibility Study (The Resource Ready Study)

Led by Barbara Ann Karmanos Cancer Institute · Updated on 2025-08-26

120

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research is focused on adults aged 18 years or older who have a past or current cancer diagnosis and live in metropolitan Detroit. The goal is to explore how well a social needs screening tool can be completed by cancer survivors and how it might help identify non-medical factors affecting their health. The study is designed to evaluate the feasibility of using this tool and to develop procedures for patient referrals and brief interventions based on social needs such as food access and digital inclusion. Participants will complete a social screening tool either in person or over the phone. Their responses will be converted into codes that highlight social factors impacting health. Based on these results, participants may be referred to community-based resources to address identified needs. Follow-up phone calls will be made at 2, 4, 6, and 8 weeks after the initial screening to monitor progress and provide support. During the study, researchers will track how many participants successfully complete the screening tool, aiming for at least an 80% completion rate. They will also evaluate the effectiveness of the referral process and interventions related to food access and digital access. This study is led by the Barbara Ann Karmanos Cancer Institute and does not involve any medical treatments but focuses on social determinants of health that may influence cancer survivors' well-being.

CONDITIONS

Brief Title

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years or older
  • Past or current diagnosis of cancer
  • Reside in metropolitan Detroit (Wayne, Oakland, Macomb counties)
  • Able to communicate in English
  • Receiving care at Karmanos Cancer Institute outpatient clinics or part of the Detroit ROCS longitudinal cohort study with past food insecurity and consent to be contacted
Not Eligible

You will not qualify if you...

  • None

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or via telephone) for social screening tool administration

Surveillance

Duration - 8 weeks

Participants are referred to community-based resources based on their screening responses and monitored over time.

Telephone follow-up calls at 2, 4, 6, and 8 weeks

Trial Site Locations

Total: 1 location

1

Karmanos Cancer Institute

Detroit, Michigan, United States, 48201

Actively Recruiting

Loading map...

Research Team

H

Hayley S Thompson, Ph.D.

A

Afsana Rinky

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Similar Trials

Receptor Radionuclide Therapy With 177Lu-DOTATOC (177Lu-edot...

Neuroendocrine Tumors

Actively Recruiting

2 locations

177Lu-DOTATATE Modified Delivery Based on Individualized Dos...

Neuroendocrine Tumors

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here